Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 33)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 PriceTarget Research, Inc. N/A ACHN has a current Overall Rating of C (Neutral). 7 $25 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A Achillion Pharmaceuticals 6 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ACHILLION PHARMA -- ACHN 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ACHN , ACEL , BDSI , IMMP , INO -- DRUGS 3 $4 View Abstract
1-Feb-10 Roth Capital Partners, Inc. Edward Nash Achillion Corporate Update: Achillion Growing On All Fronts 6 $25 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACHILLION PHARMACEUTICALS 5 $25 View Abstract
30-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Achillion Pharmaceuticals, Inc. 40 $65 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACHILLION PHARMACEUTICALS 5 $25 View Abstract
19-Jan-10 Zacks Investment Research Inc. N/A ACHILLION PHARM (ACHN) Zacks Company Snapshot 1 $10 View Abstract
19-Jan-10 Argus Research Corporation David Coleman Vickers Weekly Insider, 01/19/2010 34 $50 View Abstract
Next 20

Brokerage Reports (Showing 1 to 3 of 3)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
1-Feb-10 Roth Capital Partners, Inc. Edward Nash Achillion Corporate Update: Achillion Growing On All Fronts 6 $25 View Abstract
13-Jan-10 Roth Capital Partners, Inc. Research Department Morning Call Summary 10 $25 View Abstract
12-Jan-10 Roth Capital Partners, Inc. Edward Nash Positive Data Unrewarded, Creates A Strong Buying Opportunity 5 $10 View Abstract

Independent Reports (Showing 1 to 10 of 30)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 PriceTarget Research, Inc. N/A ACHN has a current Overall Rating of C (Neutral). 7 $25 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A Achillion Pharmaceuticals 6 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ACHILLION PHARMA -- ACHN 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ACHN , ACEL , BDSI , IMMP , INO -- DRUGS 3 $4 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACHILLION PHARMACEUTICALS 5 $25 View Abstract
30-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Achillion Pharmaceuticals, Inc. 40 $65 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACHILLION PHARMACEUTICALS 5 $25 View Abstract
19-Jan-10 Zacks Investment Research Inc. N/A ACHILLION PHARM (ACHN) Zacks Company Snapshot 1 $10 View Abstract
19-Jan-10 Argus Research Corporation David Coleman Vickers Weekly Insider, 01/19/2010 34 $50 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ACHILLION PHARMACEUTICALS 5 $25 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.